TIBER CREEK GROUP for PHRMA
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
IP and market access issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| JUSTIN MCCARTHY | — |
Copyright/Patent/Trademark CPT
Issues relating to patent reform. H.R. 9, Innovation Act. S.1137, PATENT Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| SHEILA MURPHY | — |
Health Issues HCR
Medicaid Drug Rebates. Reforms to Medicare Part D. Patent settlements. Proposed Medicare and Medicaid cuts, including proposed cuts to Medicare Part D. HRSA program regarding rebates on drugs used in the outpatient setting to help low-income/uninsured populations (340B).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| SHEILA MURPHY | — |
| JENNIFER OLSON | — |
Medicare/Medicaid MMM
Medicaid Drug Rebates. Reforms to Medicare Part D. Medicare fraud.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JONATHON JONES | — |
| ANDREW MCKECHNIE | — |
| SHEILA MURPHY | — |
Budget/Appropriations BUD
S. Con. Res.11, Senate budget resolution, HHS negotiations on drug prices to Part D.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| JENNIFER OLSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.